Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients.

Literature DB >> 17872574

Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients.

E Persico, A De Renzo, V La Mura, S Bruno, M Masarone, R Torella, M Persico.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2007 PMID： 17872574 PMCID： PMC2000268 DOI： 10.1136/gut.2007.128777

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

9 in total

1. Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma.

Authors: Marcello Persico; Fedele De Marino; Giovanni Di Giacomo Russo; Aristide Morante; Bruno Rotoli; Roberto Torella; Amalia De Renzo
Journal: Blood Date: 2002-01-15 Impact factor: 22.113

Review 2. Occult hepatitis B virus infection.

Authors: Giovanni Raimondo; Teresa Pollicino; Irene Cacciola; Giovanni Squadrito
Journal: J Hepatol Date: 2006-11-07 Impact factor: 25.083

3. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.

Authors: Chee-Kin Hui; Winnie W W Cheung; Hai-Ying Zhang; Wing-Yan Au; Yui-Hung Yueng; Anskar Y H Leung; Nancy Leung; John M Luk; Albert K W Lie; Yok-Lam Kwong; Raymond Liang; George K K Lau
Journal: Gastroenterology Date: 2006-07 Impact factor: 22.682

4. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.

Authors: I Cacciola; T Pollicino; G Squadrito; G Cerenzia; M E Orlando; G Raimondo
Journal: N Engl J Med Date: 1999-07-01 Impact factor: 91.245

5. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance.

Authors: R Fukuda; N Ishimura; M Niigaki; S Hamamoto; S Satoh; S Tanaka; Y Kushiyama; Y Uchida; S Ihihara; S Akagi; M Watanabe; Y Kinoshita
Journal: J Med Virol Date: 1999-07 Impact factor: 2.327

6. Hepatitis B infection in patients with lymphomas.

Authors: R H Liang; A S Lok; C L Lai; T K Chan; D Todd; E K Chiu
Journal: Hematol Oncol Date: 1990 Sep-Oct Impact factor: 5.271

Review 7. Transmission of hepatitis B infection from hepatitis B core antibody--positive livers: background and prevention.

Authors: M Rizzetto
Journal: Liver Transpl Date: 2001-06 Impact factor: 5.799

8. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients.

Authors: J Y Lau; C L Lai; H J Lin; A S Lok; R H Liang; P C Wu; T K Chan; D Todd
Journal: Q J Med Date: 1989-10

Review 9. Use of hepatitis B core antibody-positive donors for liver transplantation.

Authors: Santiago J Muñoz
Journal: Liver Transpl Date: 2002-10 Impact factor: 5.799

9 in total

5 in total

1. Patients with hematological malignancies and serological signs of prior resolved hepatitis B.

Authors: Massimo Marignani; Elia Gigante; Paola Begini; Alfredo Marzano; Michela di Fonzo; Ilaria Deli; Sara Gallina; Maria Christina Cox; Gianfranco Delle Fave
Journal: World J Gastrointest Oncol Date: 2012-03-15

2. Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis.

Authors: Zilin Tang; Xiaodong Li; Shunquan Wu; Yan Liu; Yan Qiao; Dongping Xu; Jin Li
Journal: Hepatol Int Date: 2017-08-30 Impact factor: 6.047